На главную
Результаты поиска “U.S. Pharmaceutical Sales Statistics” за 2016
Opioids: Last Week Tonight with John Oliver (HBO)
 
19:23
John Oliver discusses the extent and root of the nation’s epidemic of opioid addiction. Connect with Last Week Tonight online... Subscribe to the Last Week Tonight YouTube channel for more almost news as it almost happens: www.youtube.com/user/LastWeekTonight Find Last Week Tonight on Facebook like your mom would: http://Facebook.com/LastWeekTonight Follow us on Twitter for news about jokes and jokes about news: http://Twitter.com/LastWeekTonight Visit our official site for all that other stuff at once: http://www.hbo.com/lastweektonight
Просмотров: 10194655 LastWeekTonight
Industrys Influence in Medicine: Duped, Doped and Dying in America by Gwen Olsen
 
01:23:54
Expert Panel Host: Gwen Olsen (A podcast version of this video is available on iTunes.) • On December 2, 2004, Gwen Olsen's niece Megan committed suicide by setting herself on fire-and ended her tortured life as a victim of the adverse effects of prescription drugs. Gwen Olsen offers an honest glimpse into alarming statistics and a health care system ranked last among nineteen industrialized nations worldwide. As a former sales representative in the pharmaceutical industry for several years, Olsen learned first hand how an unprecedented number of lethal drugs are unleashed in the United States market, but her most heartrending education into the dangers of antidepressants would come as a victim and ultimately, as a survivor. Gwen Olsen shares one woman's unforgettable journey of faith, forgiveness, and healing. “Gwen Olsen spent fifteen years as a pharmaceutical sales rep working for such healthcare giants as Johnson & Johnson, Bristol-Myers Squibb, and Abbott Laboratories. She enjoyed a successful, fast-paced career until several conscious-altering experiences began awakening her to the dangers lurking in every American medicine cabinet. Her most poignant lessons, however, came as both victim and survivor of life-threatening adverse drug reactions. Gwen Olsen is the author of the award-winning book, Confessions of an Rx Drug Pusher.She is also a contributing author to three books, Drugging Our Children by Dr. Sharna Olfman et al, Doctor of the Futureby Dan Yachter, D.C., and the Maximized Living Makeover Manualby Dr. Ben Lerner et al. Gwen has also published health-related articles in the Well Being Journal, Natural News, and the Health News Digest. Gwen is a passionate mental health activist, writer, and dynamic speaker who devotes much of her time to mental health and child advocacy. Gwen volunteered as a Court Appointed Special Advocate (CASA) for the Travis County court system from 1995 to 2000, serving as an advocate for abused and neglected foster children in Texas. A 2007 Human Rights Award recipient, she is sought after internationally as a speaker and media resource, and has testified numerous times before Congress and the FDA. A fifteen-year-veteran pharmaceutical rep from 1985 – 2000, Gwen worked for McNeil Pharmaceutical, Syntex Laboratories, Bristol-Myers Squibb, Abbott Labs and Forest Laboratories. She was a hospital rep and specialist rep for the majority of her career, educating residents in hospital teaching settings and selling prescription drugs to doctors in obstetrics and gynecology, orthopedics, cardiology, neurology, endocrinology and psychiatry.She has a unique industry insider’s perspective of the current U.S. healthcare dilemma, and utilizes both her experience and the insight she received in her extensive sales training with Pharma to illuminate marketing trends and illustrate how current greed and conflicts of interest make the system itself the biggest health risk to American consumers.”
Просмотров: 8520 The Real Truth About Health
Getting under the skin of the cosmetics industry
 
11:25
Subscribe to France 24 now : http://f24.my/youtubeEN FRANCE 24 live news stream: all the latest news 24/7 http://f24.my/YTliveEN In this edition, France in Focus gets up close and personal as we take a look at the country's second biggest export: cosmetics! From the world's most famous brands to the newcomers who want French beauty to be more than just skin deep, we'll tell you about the trends and technology coming soon to a bathroom near you! With thanks to: Galeries Lafayette http://www.galerieslafayette.com/ Les Ateliers de la Souris Verte http://www.ateliers-souris-verte.com/ Visit our website : http://www.france24.com Subscribe to our YouTube channel : http://f24.my/youtubeEN Like us on Facebook : https://www.facebook.com/FRANCE24.English Follow us on Twitter : https://twitter.com/France24_en
Просмотров: 6582 FRANCE 24 English
Global Pharmaceutical Anti-Counterfeiting Technologies Consumption Industry 2016 Market Research
 
00:31
The Global Pharmaceutical Anti-Counterfeiting Technologies Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Pharmaceutical Anti-Counterfeiting Technologies market. First, the report provides a basic overview of the Pharmaceutical Anti-Counterfeiting Technologies industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Pharmaceutical Anti-Counterfeiting Technologies market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Get Discount on This Report: http://www.researchnreports.com/ask_for_discount.php?id=3149 Third, the Pharmaceutical Anti-Counterfeiting Technologies market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What?s more, the Pharmaceutical Anti-Counterfeiting Technologies industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Complete Report Available at: http://www.researchnreports.com/pharma-healthcare/Global-Pharmaceutical-Anti-Counterfeiting-Technologies-Consumption-2016-Market-Research-Report-3149
Просмотров: 2 vil Kudl
#SalesChalkTalk Presents - You've Been Promoted! From Sales Rep to CEO. Sales Training
 
59:01
In this 1 hour sales mindset training taken from #SalesChalkTalk, you will hear from 3 of the worlds top sales and motivational experts. They will answer "Why do you need to view yourself as the CEO of your sales business and How do you do it?" Subscribe Now to our YouTube Channel for sales and social selling training http://bit.ly/M3JrYouTubeSubscribe. The Panelists 1. Jim Cathcart, The Motivation Expert™ http://RelationshipSelling.com 2. Jeff Seeley, CEO of Carew International https://www.Carew.com/ 3. Mark Hunter, Author, The Sales Hunter http://theSalesHunter.com/ For more Sales Training, Social Selling training and Personal Branding Tips by Mario Martinez Jr., visit https://www.m3jr.com and follow the social channels below! Subscribe to our Newsletter: https://m3jr.com/contact-us/get-our-newsletter Facebook: https://facebook.com/M3JrGrowthStrategies YouTube: https://youtube.com/M3JrGrowthStrategies Google+: https://google.com/+M3jrGrowthStrategies Twitter: https://twitter.com/M3JrGrowth LinkedIn: https://linkedin.com/company/m3jr-growth-strategies-llc
Просмотров: 168 Vengreso
Do You Actually Need A Multivitamin?
 
04:05
The supplement industry is a multi billion dollar revenue stream for thousands of companies. Staggering numbers show supplement sales reached 37 billion dollars in 2015 and that number is constantly growing. A multivitamin is the one of the most common supplements sold since it covers a broad range of vitamins and minerals in a single dose. Trouble is, do you know if the multivitamin is actually helping or hurting you? According to several recent studies, many people are taking too much of particular vitamins, increasing their chances for cancer and heart disease. Here are some examples: • Beta Carotene may increase lung cancer and heart disease • Folic Acid may increase colon polyps • Vitamin E may increase prostate cancer • Selenium may increase prostate cancer With all the ads and recommendations for supplements, what do you choose? The best way to know if you actually need a supplement is to check through lab testing, specifically a Micronutrient test. Learn more about this test at http://www.renuehealth.com/micronutrient-testing/ Finally, choose the right supplements. The supplement industry is unregulated and there are lots of poor quality products being sold with no consistency or oversight in the manufacturing process. Recent reports from consumer reporting agencies show that many top brands in big chain stores were actually nothing but fillers! Talk about throwing money away! Choose reputable supplement companies that operate under pharmaceutical guidelines for quality and consistency. Some of those include Metagenics and Pure Encapsulations. If you are not sure, don't buy it without doing your research. To learn how the ReNue Health Opportunity can help restore your youth and vitality, simply call 937-350-5527 or visit us at http://www.renuehealth.com/
Просмотров: 61 Renue Health
Tildatech Pharma-Track Highlights Code of compliance software solution for Pharmaceutical companies2
 
01:37
For more email us on info@tildatech.co.za Or call on: 011 823 6773 See more: Informal Meeting and Approval Process Demo https://youtu.be/J8lu4K1rArQ Read more...Case Study: http://www.tildatech.co.za/Downloads/CaseStudy-AspenPharmacareSA-RepAssist.pdf Read more...Press Release: http://www.tildatech.co.za/PressReleaseJune2015.aspx As a code of compliance software solution developed by Tilda Technologies, Pharma-Track, created for pharmaceutical companies, not only, captures, tracks and monitors the Informal and Formal meeting approval process in line with the South African marketing code of practice, as set out by the marketing Code Authority, but it also improves turnaround times. Website: www.tildatech.co.za
Просмотров: 59 Tildatech
McCaskill: This Business Model Uses Patients as Hostages
 
01:32
U.S. Senator Claire McCaskill sharply questioned officials and investors of Valeant Pharmaceuticals about the company’s business strategy—which relied upon aggressive corporate acquisitions and price hikes. The hearing also included testimony from individuals and experts who explained the negative impact for individuals caught in Valeant’s ‘price-gouging’ practices. “You can try to dress up this business model with good sounding phrases but (the model) is simple...give the companies that develop a drug that has little to no competition a healthy profit, fire the scientists, and jack up the prices as high as you think you can get away with,” McCaskill said. “It’s using patients as hostages. It's immoral. It hurts real people. It makes Americans very very angry. In case you haven't noticed that has real ramifications in our political process and could lead to an instability of our government, our economy, and our standing in the world. Pigs get fed, hogs get slaughtered. It's time to slaughter some hogs.” Valeant consistently acquired pharmaceutical companies that were the only producer of off-patent drugs, often then slashing the research and development spending for those companies and raising the prices on their recently-acquired drugs by hundreds or thousands of percentage points. Valeant’s entire research and development budget was consistently below 5 percent of their total sales—dramatically lower than most other companies in the pharmaceutical industry. One of the witnesses Berna Heyman, who had lost access to the drug Syrine, which is used to treat Wilson’s disease after a dramatic and sudden price increase said, “I’m very proud to see this (hearing) in action. That the committee agreed to look at this issue is doing something for so many of us.”
Просмотров: 509 Senator Claire McCaskill
Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S: Oral Argument - December 05, 2011
 
01:01:41
Facts: Novo Nordisk sued Caraco Pharmaceutical Laboratories and Sun Pharmaceutical Industries Ltd. for infringement in the wake of Caraco filing an abbreviated new drug application ("ANDA") for a generic version of the Type 2 diabetes drug Prandin. Caraco and Sun promptly countersued. While the litigation was pending, Novo changed the FDA Orange Book's use code — a description of the scope of the patent —undermining Caraco's argument that patent did not apply to the purpose for which the generic product would be marketed. Caraco filed a counterclaim requesting an order that would require Novo Nordisk to change back the use code. The Medicare Prescription Drug, Improvement and Modernization Act of 2003 authorized ANDA applicants to assert a counterclaim seeking an order requiring the brand to correct or delete submitted patent information on the grounds that the patent does not claim 1) the drug for which the brand's new drug application was approved or 2) an approved method of using the drug. The U.S. District Court for the Eastern District of Michigan granted the counterclaim and issued an injunction ordering Novo Nordisk to change the code. Novo appealed to the United States Court of Appeals for the Federal Circuit, arguing that the district court had abused its discretion. The Federal Circuit ruled in favor of Novo, holding that Caraco could only assert a counterclaim if Novo's patent did not claim any approved method of use. Question: (1) Does the counterclaim provision of the Hatch-Waxman Act only apply if Novo's Prandin patent does not claim any approved method of use? (2) Does Novo's use code for Prandin qualify as "patent information submitted under subsections (b) and (c)" for the purposes of the act? Conclusion: Yes and yes. In a unanimous decision written by Justice Elena Kagan, the Court held that the Hatch-Waxman Act allows counterclaims to challenge unpatented uses of generic drugs even if other approved uses are still under patent. Justice Kagan looked to the language and purpose of the statute, focusing on the meaning of the phrase, "the patent does not claim... an approved method of using the drug." While acknowledging that the words "not an" could be interpreted to mean "not any," as Novo suggested, Justice Kagan rejected Novo's argument that the counterclaim right evaporates if Novo has a patent over another use not claimed or contested by Caraco and Sun. She argued that the act's counterclaim provision essentially allows a generic drug marketer to challenge a brand's assertion of rights over whichever use the generic drug marketer wishes to pursue. Justice Kagan noted that if Congress intended Novo's "not any" interpretation, it could have used that exact phrasing. Justice Kagan also held that Novo's use code was "patent information submitted by the brand under subsection (b) or (c)" for the purposes of the act. She pointed out that the use code describes the methods of use claimed in a patent, and must qualify as "patent information" under any ordinary understanding of that phrase. Looking to the Court's precedent, Justice Kagan determined that information "submitted under" a federal law suggests doing so in furtherance of or in compliance with a comprehensive scheme of regulation. Justice Kagan noted that subsections (b) and (c) provide the basis for the regulation requiring brands to submit use codes and dictate the form of those submissions; thus, a brand use code is "submitted under" sections (b) and (c). She rejected Novo's argument that congress only intended to allow generic drug marketers to correct improperly numbered or listed patents. For more information about this case see: https://www.oyez.org/cases/2011/10-844 Section 1: 00:00:05 Section 2: 00:15:54 Section 3: 00:26:21 Section 4: 00:56:28 PuppyJusticeAutomated videos are created by a program written by Adam Schwalm. This program is available on github here: https://github.com/ALSchwalm/PuppyJusticeAutomated The audio and transcript used in this video is provided by the Chicago-Kent College of Law under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License. See this link for details: https://creativecommons.org/licenses/by-nc/4.0/
Просмотров: 94 PuppyJusticeAutomated
How Much Does A Sales Rep Make
 
05:40
http://adfreewebsite.com - How Much Does a Sales Rep Make Most people looking to step into the sales realm ask, ‘How much does a sales rep make? The simple answer is that the amount can vary between $50,000 to $1,500,000 depending on what path to follow. Instead of asking the question “How much does a sales rep make” the more important question to ask is “what is the opportunity that is being presented?” Four key elements that should shape your decision about the opportunity. 1) Does the market niche have a large group of consumers or customers that are passionate or have a never ending need for the product or service? 2) Is this niche expected to significantly expand in the future? 3) Does the company’s product have a significant advantage when compared to its competitors. Will this advantage allow you to sell it for more money? 4) What is the amount of income that the top sales rep earn in the company and would that be an amount that you would be ecstatic about. There are a multiple options available, probably some you haven’t thought about. Go to our ad free content only website adfreewebsite.com to see what other opportunities are out there. Other url links about How Much Does A Sales Rep Make are: 10 Companies That Pay Salespeople Really Well - Forbes http://www.forbes.com/sites/jacquelynsmith/2011/05/20/10-companies-that-pay-salespeople-really-well/#e7b303e592d2 Forbes May 20, 2011 - On average, sales representatives for wholesalers and manufacturers of technical and scientific products make $84,360 in base salary and commission, according to a Bureau of Labor Statistics survey that reflects salary data from May 2010. Sales Representative Salaries by education, experience, location and ... http://www1.salary.com/Sales-Representative-Salary.html Sales Representative salaries, benefits packages, yearly bonuses, job descriptions, statistics and available ... How much does a Sales Representative make? How Much Should You Pay Your Sales Reps? | PROFITguide.com http://www.profitguide.com/manage-grow/sales-marketing/how-much-should-you-pay-your-salespeople-52411 Profit Jul 17, 2013 - At the highest level, a sales rep might be getting $80,000 or they might get $130,000. So, how do you stop yourself from making a $50,000 ...
Просмотров: 2452 Adfree Website
Trucking industry in the United States
 
27:00
The trucking industry serves the American economy by transporting large quantities of raw materials, works in process, and finished goods over land—typically from manufacturing plants to retail distribution centers. Trucks are also used in the construction industry, as dump trucks and portable concrete mixers move the large amounts of rocks, dirt, concrete, and other building materials used in construction. Trucks in America are responsible for the majority of freight movement over land, and are tools in the manufacturing, transportation, and warehousing industries. Large trucks and buses require a commercial driver's license to operate. Obtaining a CDL requires extra education and training dealing with the special knowledge requirements and handling characteristics of such a large vehicle. Drivers of commercial motor vehicles must adhere to the hours of service, which are regulations governing the driving hours of commercial drivers. These, and all other rules regarding the safety of interstate commercial driving, are issued by the Federal Motor Carrier Safety Administration. The FMCSA is a division of the United States Department of Transportation, which governs all transportation-related industries such as trucking, shipping, railroads, and airlines. Some other issues are handled by another branch of the USDOT, the Federal Highway Administration. This video is targeted to blind users. Attribution: Article text available under CC-BY-SA Creative Commons image source in video
Просмотров: 885 Audiopedia
Credit Suisse Downgrades Sun Pharma To ‘Neutral’ Vs Outperform
 
00:44
Credit Suisse downgrades Sun Pharma to ‘neutral’ vs outperform. Ekta Batra gets us the details.
Просмотров: 49 CNBC-TV18
SAS Training Beginners Must Watch Video
 
13:01
SAS Training Beginners Must Know What is SAS? SAS Online Training For SAS Programming with SAS Software Tutorials For SAS Certification and SAS jobs. SAS Full Form Is Statistical Analysis System/software. SAS Training at http://www.eduemaster.com/ makes students proficient in SAS .It provides Base SAS, Advance SAS,SQL, Macros, Clinical SAS(CDISC) training. SAS Training will be provided by certified trainers having above 6 years real time experience. Training will be in such a way that even a layman can understand. Register For Live Demo: http://www.eduemaster.com/contact-us/ Mail : contact@eduemaster.com Whatsapp : +91 9912025945 , +44 7760860100 Phone : IND +91 9912025945 U.S.A + 1 (917)-310-3073 U.K +44 7760860100
Просмотров: 24983 SAS Online Training
How This $1.6 Billion Company May Change A $10 Billion Market
 
06:06
Demand for a new class of anticoagulants is soaring, but sales of them could climb even higher if Portola Pharmaceuticals antidote wins FDA approval this year. This podcast was recorded on Feb. 24, 2016. Imagine owning Amazon.com (up over an insane 4,000% since 2001) when Internet sales rendered big-box retailers obsolete... Now an industry 99% of us use daily is set to implode... And 3 established companies are positioned to take advantage. Click http://bit.ly/1zQXjzy for a stunning presentation. ------------------------------------------------------------------------ Subscribe to The Motley Fool's YouTube Channel: http://www.youtube.com/TheMotleyFool Or, follow our Google+ page: https://plus.google.com/+MotleyFool/posts Inside The Motley Fool: Check out our Culture Blog! http://culture.fool.com Join our Facebook community: https://www.facebook.com/themotleyfool Follow The Motley Fool on Twitter: https://twitter.com/themotleyfool
Просмотров: 497 The Motley Fool
Fentanyl: The Drug Deadlier than Heroin
 
52:09
VICE presents an immersive and personal feature film about the fentanyl crisis in Canada told from the perspective of a community of drug users. This video has been edited from its original version due to privacy concerns surrounding one of its subjects. WATCH NEXT: Black Widow: Dominating the Masculine World of Boxing: http://bit.ly/28UgNhS Watch more of our documentaries on drugs: http://bit.ly/2aB0DuG Click here to subscribe to VICE: http://bit.ly/Subscribe-to-VICE Check out our full video catalog: http://bit.ly/VICE-Videos Videos, daily editorial and more: http://vice.com More videos from the VICE network: https://www.fb.com/vicevideo Like VICE on Facebook: http://fb.com/vice Follow VICE on Twitter: http://twitter.com/vice Read our Tumblr: http://vicemag.tumblr.com Follow us on Instagram: http://instagram.com/vice Check out our Pinterest: https://pinterest.com/vicemag
Просмотров: 6144869 VICE
Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025
 
00:36
Clinical Trials – Discover Commercial Potentials of Outsourced Drug Testing, Benefiting Your Authority What does the future hold for pharmaceutical clinical research providers? Visiongain’s new study gives you multilevel revenue forecasts from 2015 to 2025. It explains trends, opportunities and selling prospects for that drug development and testing. Our report predicts sales at overall world market, submarket and national level. There you find the most promising and lucrative parts of clinical trial outsourcing, helping your research and analysis. That way stay ahead, saving time and hassle, also benefiting your influence. Clinical research organisations (CROs) and drug companies using them will benefit from expansion of that industry and market. Those technologies and outsourced services hold rising importance in pharmaceutical R&D. See why and how, finding the gains possible. Read on, then, to explore those contracting services for benefiting medicine. Find what influences that market and see predicted revenue. Forecasts and other analyses to help you stay ahead in knowledge Why struggle to find information or miss data you need on clinical outsourcing and off-shoring? Instead reduce worry there, helping your searches, proposals and presentations. So in our work discover where the money lies, and best places for business expansion. In that study you explore revenue forecasting to 2025, results and other statistics, growth rates, leading companies and market shares. You also assess qualitative analysis (SWOT and STEP), news, business progress, outlooks and developmental needs – pharma R&D trends and demands. You find expected gains. There you get 78 tables, 65 charts and interviews with three companies. The clinical testing market will increase its revenues from 2015 to 2025, achieving strong sales expansion. Our survey’s purpose is to explain those needs, opportunities and potentials. For an Executive Summary of this report please contact sara.peerun@visiongainglobal.com (+44 (0) 20 7336 6100) or refer to our website: https://www.visiongain.com/Report/1458/Pharma-Clinical-Trial-Services-World-Industry-and-Market-Prospects-2015-2025
Просмотров: 57 visiongain
The Most Profitable Company In The US Didn't Top The Fortune 500 List
 
01:20
This year marks Fortune magazine's 62nd annual ranking of the U.S.' 500 largest companies. Combined, this year's contenders earned $12 trillion in revenues. Wal-Mart once again tops the Fortune 500 list, which was released Monday.  Wal-Mart boasts the second-largest online revenue among American companies. And Fortune reports Wal-Mart earned $482 billion in total revenue last year.  Still, the company's total revenue in 2015 decreased for the first time in roughly 45 years.  Wal-Mart blamed the drop in sales on store closures and currency exchange rates.  Ranking second on the Fortune 500 list was oil and gas company Exxon Mobil, whose total revenue numbers were about half that of Wal-Mart.  And Apple was ranked third this year, despite actually being the most profitable company on the list. It made more than $53 billion in profits in 2015; however, Fortune's list is based on revenue.  Warren Buffett's Berkshire Hathaway and pharmaceutical distributor McKesson placed fourth and fifth, respectively, though Fortune seemed to hint that McKesson might not remain in that coveted spot next year if Walgreens ends up acquiring Rite Aid, which has a distribution deal with the company.  UnitedHealth Group, CVS Health, General Motors, Ford Motor and AT&T round out the list's top 10.  Other notable companies to make the Fortune 500 list include Amazon, Boeing, Wells Fargo, Target and Starbucks. Even Campbell's Soup earned a spot, coming in at No. 337.  For more details on the rankings, head on over to Fortune's website.  This video includes clips from Wal-Mart, Apple and Walgreens and images from Getty Images. Music provided courtesy of APM Music. Newsy is your source for concise, unbiased video news and analysis covering the top stories from around the world. With persistent curiosity and no agenda, we strive to fuel meaningful conversations by highlighting multiple sides of every story. Newsy delivers the news and perspective you need without the hype and bias common to many news sources. See more at http://www.newsy.com/ Like Newsy on Facebook: http://www.facebook.com/newsyvideos/
Просмотров: 2498 Newsy
First Trade | Torrent Pharma currently trading at 1480 with 5.86% downfall
 
11:09
Torrent Pharma currently trading at 1480 with 5.86% downfall. Watch complete news story of First Trade and stay updated with the latest trends and statistics in the stock market, commodity market and share market! Zee Business is one of the leading and fastest growing Hindi business news channels in India. The channel has revolutionized business news by its innovative programming and path-breaking strategy of making business news a 24/7 activity as it is not just limited to the stock market. This has made Zee Business your channel to wealth and profit. Besides updated hourly news bulletins, there is a lot to watch out for, whether it be stock market related detailed information, investments, mutual funds, corporate, real estate, travel or leisure. The channel has the most diverse programming portfolio which has positioned it as a channel of choice amongst viewers. By speaking a language of the masses, Zee Business is today the most preferred for business news. Some of the popular shows of Zee Business are: Share Bazar, Mandi Live, Aap Ka Bazar, First Trade, Big Debate etc.
Просмотров: 119 ZeeBusiness
Global Diabetic Retinopathy Drug Consumption 2016 Market Research Report
 
00:31
The Global Diabetic Retinopathy Drug Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Diabetic Retinopathy Drug market. First, the report provides a basic overview of the Diabetic Retinopathy Drug industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Diabetic Retinopathy Drug market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Get Discount on This Report: http://www.researchnreports.com/ask_for_discount.php?id=3138 Third, the Diabetic Retinopathy Drug market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What?s more, the Diabetic Retinopathy Drug industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered. In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Complete Report Available at: http://www.researchnreports.com/pharma-healthcare/Global-Diabetic-Retinopathy-Drug-Consumption-2016-Market-Research-Report-3138
Просмотров: 1 rup galpalli
Motivational Speaker Insurance Companies National Sales Conventions, Conferences & Events
 
00:46
Hire one of the greatest Motivational Speakers for your Insurance National Sales Convention, Insurance services company’s conference & Mutual Funds Annual Convention, Meeting & Tradeshow. If you are one of the top insurance companies like FM Global, Sompo Japan Nipponkoa Holdings, Covea, HDI, Esure, CV Starr, Hisoc, Aviva, Bupa, Catlin, AMTrust Europe, Berkshire Hathaway, Munich Re, Allianz, HCC, Legal & General, Co-operative, Genworth Financial, AIG, RSA, Ageas, WR Berkley, then you hold conferences, events, summits and expos on a regular basis. William Arthur Ward once said, “The mediocre teacher tells. The good teacher explains. The superior teacher demonstrates. But the great teacher inspires”. And that is exactly what The Man Inspiring Millions can do for your Insurance & Mutual Fund Financial services Teams, Customers and Partners at your convention and conference. Dates are limited. Enquire for this top motivational speaker to insurance companies and mutual funds here ►http://goo.gl/qcrOMW Subscribe To the channel of The Man Inspiring Millions Here ► http://goo.gl/xWRDyW ►What if your team of insurance associates and mutual funds executives, your customers and partners all got sparked at your next event? Take a look https://www.youtube.com/watch?v=h-ac4fnmztc Let me ask you guys at London General Insurance, Ecclesiastical, QBE, LV=, NFU Mutual, AXA, Lanchashire, Markel Corporation, Domestic & General, Direct Line Group, XL Group, Travelers, Tokio Marine, MS&AD, British Gas Insurance, Aspen, CAN, Cardif Pinnacle, Lloyds Banking Group, Zurich, SCOR, ACE, Admiral, Liberty Mutual, Arch Capital Group, Chubb, Sabre, Assurant, any other insurance company in the sector. What if your team of insurance associates are ignited to become the best they have ever been this year? How much would that be worth to you? The insurance sector is continuously facing changing and challenging times. Would you like your people to handle situations with commanding control? When most sales executives have their tail between their legs, would you like your executives to capture more market share? Would you like to increase the number of your insurance consultants top performers? ► As an Engaging motivational sales keynote speaker who speaks in a manner that connects with his audience from the insurance background, Kevin Abdulrahman familiarity with the insurance industry enables him to work closely with your people tackle the challenges and provide your insurance associates with the tools and mindset to breakthrough their challenges and break out sales records. Let Kevin Abdulrahman The Man Inspiring Millions deliver his sales keynote speech, deliver a half day sales workshop or conduct full day sales seminars where he will share tips, thoughts and strategies on how to break through their current sales numbers. More videos from our Motivational Sales Keynote Speaker for your Insurance National Sales Convention, Insurance services company’s conference & Mutual Funds Annual Convention, Meeting & Tradeshow. ►Motivational Speaker International Sales Convention. Regional Sales Conference. Global Sales Summit. Annual Sales Leadership https://www.youtube.com/watch?v=WUZ3TwoPIa0 ►Motivational Speaker for Corporate Events, Annual Meetings and Business Conferences https://www.youtube.com/watch?v=6sUG-p0Q5xE ►Motivational Speaker Leadership Sales Convention. National Sales Conferences. Regional Sales Events. Global Sales & Marketing Summits https://www.youtube.com/watch?v=CQfEkMTAGqI&t=12s ►Motivational speaker pharmaceutical & biotech sales conventions, marketing conferences and education summits https://www.youtube.com/watch?v=eeQFrlsS_Ic ► More Videos Of our Motivational Speaker to Fortune 500, Global 500, Fortune 1000 and Fast Growth Companies. https://www.youtube.com/watch?v=ycbF2i5Z18A ►Motivational Speaker on Creativity & Innovation https://www.youtube.com/watch?v=nG7eookYrlk ►Visit http://goo.gl/qcrOMW to book Kevin Abdulrahman as your inspiring, engaging and thought evoking Motivational Speaker for your next International Insurance Convention, National Sales Conference, Insurance services company’s & Mutual Funds Annual Meeting & Tradeshows. . ►Like us on Facebook: https://www.facebook.com/BestLeadershipSpeakerAsia ►Follow us on Twitter: https://twitter.com/BestSpeakerAsia ►Instagram: https://www.instagram.com/kevin_abdulrahman ►Motivational Keynote Speaker for Insurance Companies Profile http://goo.gl/ICXTNu ►Insurance executives Training on Public Speaking, Media, Negotiations & Presentation Skills Training http://goo.gl/GltOFu
Просмотров: 1372 Kevin Abdulrahman
How Top Companies Develop Product Launch Messaging
 
29:25
Today’s topic is Product Launch and Messaging. Joining us is Rob Lips, Vice President of U.S. Sales and Channel Marketing at Intuit. Rob lead sales, channel marketing and analytics across Intuit’s retail, e-tail, inside sales, resellers, OEMs and financial Institutions. He is responsible for a +$900M business with a team of over 500 people. Product launches fail to generate revenue when sales people and channel partners are not involved in messaging development during prelaunch preparations. When messaging is developed in isolation it is not compelling enough to get your customers to act. Stories told directly to customers by well-trained sales channels enable customers and prospects to answer “Why change?” and this stimulates latent demand while leading to exceptional revenue growth. Watch as Rob talks through the messaging and storytelling approach based on his experience of successfully launching many products. Success requires sales reps to defeat the status quo. Rob explains how to develop and roll-out messaging where sales can tell stories about somebody else who in a similar situation took the plunge, and how they used your products and services to get to a better outcome.
Просмотров: 238 SBI TV
Explainer video Alpen Animation MedTech SC Pharmaceuticals
 
02:04
Alpen Animation is a video production company for highly effective explainer videos. Use our top ranking explainer videos to explain your business, product, app or service. We offer affordable prices. This video was produced for ... to explain "...". ... is offering several advantages and benefits which are described in this video animation. Only professional copywriters who have many years in writing selling copy, will write your script! We want your video to rank highly and to convert. Therefore, before we produce your video, we analyze your market and - more important - what your customers are looking for exactly when they search for your product or service. For example, what keywords are they searching in google and youtube? This way, we can increase the probability that your video will rank highly. Most explainer videos do not respect the "rules" of youtube and google ranking. We do! We keep our animated explainer videos as simple as possible, as we want a maximum of people to understand them. Good explanation videos get the message accross in about 60-90 seconds - anything else is considere to be too long and people won't watch the full length of your video. We have used videos ourselves for more than 15 years in sales and marketing. We know from our own experience how much you can increase your sales by using explainer videos. You can use them not only as web videos and online marketing, but also: - on your customers' webpages - for online stores - for sales presentations and crowdfunding, as kickstarter video - during shows and exhibitions - at the Point of Sales (POS) on digital signage screens A 1 minute video shows and explains according to recent statistics more than 1.8 million words. Just watch the video above and imagine yourself how many words you would need to describe the situation, the emotions, the story. Explainer videos tell a story which will help to sell your product. They are far more enganging and entertaining than just words and people remember a video easier than lenghty verbal descriptions. ALPEN ANIMATION: we will produce your video with passion and give you all the service you expect. We are speaking several languages and have native speaking people in our team for English, Spanish, French, German, Polish, Russian, Ukrainian, Norwegian, Swedish, Italian! this will help you a lot in getting a convincing script. We can offer any style of explainer videos - ideally just send us a video you like and we can adapt. For example: - whiteboard animation explainer video - 2D and 3D animations - comic style - Infographics - Motion Graphics Looking forward to hearing from you, contact frank.metzel@gmail.com for further information. Please subscribe to our channel and send us your comments and how you like or dislike our videos. We are always interested in our viewers' feed-back as this is the only way to improve our explainer videos and our explanations. Visit also: www.alpenanimation.com Looking forward to hearing from you, contact frank.metzel@gmail.com for further information.
Просмотров: 372 AlpenAnimation
Option chain explained - How to setup, use, & read an option chain - Options Trading Tutorial - TOS
 
15:21
With Netflix earnings bringing about a huge gain today, I thought this tutorial on options trading is more than relevant. Another in depth Tutorial by one of the awesome options traders at The Trading Fraternity. Brendan explains the option chain and how to setup the options chain using ThinkOrSwim (TOS). Brendan goes in depth on how to setup the options chain and what everything means from the bid and ask, all the way to the deltas, open interest and expirations. Given all these things are crucial to options trading, it is vital you understand all the concepts at hand not only so you know what you are doing, but also so you don’t make any mistakes, especially if you are trading with your hard earned money. Again, that is why we always recommend you paper trade, play around and familiarize yourself with the trading platform before trading live. Mess around with the chain and fully understand how to use it, set it up, navigate, and read/interpret what is before you. There are a lot of things on the platform to use and a lot of things you need to know and educate yourself on if you want to trade options successfully. Understanding the platform and the basics of how an options chain will serve as the fundamentals of learning because this is where you will be looking for options to buy and placing your options trades. I suggest you guys go through the video slowly, take notes and ask me any questions or things you do not understand. Though it may seem intimidating at first for new traders, once you get the hang of it and understand everything, you will see how intuitive options trading is, there is just a high learners curve. Please SUBSCRIBE to the channel LIKE, SHARE, and COMMENT so I have questions to answers and things to talk about. If you think you can hang with the brothers and are qualified to be one of the 25 people we accept every quarter to join my 3-month mentoring program, where you are able to watch me trade stocks LIVE every second of the day, every day of the week and be able to ask me questions live while I trade, go to http://www.thetradingfraternity.com to request and application. The lazy an un-dedicated need not apply. If you haven't done so follow me on social media! Twitter: http://www.twitter.com/JoshAnswers instagram: http://www.instagram.com/TheTradingFraternity Facebook: http://www.facebook.com/TradingFraternity Sign up to be a TTF Citizen and get access to our private LIVE webinars 2x a week, private newsletter, and chatroom!: http://www.TTFCitizen.com Apply for mentorship: http://www.TheTradingFraternity.com The trading fraternity, the trading fraternity review, the trading fraternity scam, TTFCITIZEN, josh answers, how to trade stocks, how to trade options, how to trade penny stocks, penny stocks for beginners, options trading for beginners, day trading, options trading, day trading lessons, trading options, option trading, dough.com, tastytrade, binary options, options trader, real estate, how to become a real estate agent, real estate agent, real estate tips, how to flip a house, how to flip a home, entrepreneur, stock market, forex, wall street, improve, fundamental analysis, technical analysis, economy, tdameritrade, etrade, money, thinkorswim beginners, etrade pro, etrade pro beginners, best broker
Просмотров: 11106 Trading Fraternity
Focusing On Specialty Pharma Currently: Biocon
 
07:19
Kiran Mazumdar Shaw, CMD, Biocon states that the company is focusing on specialty pharma currently.
Просмотров: 217 CNBC-TV18
Global Pneumonia Vaccine Consumption Industry 2016 Market Forecasts to 2021 and Analysis
 
00:31
The Global Pneumonia Vaccine Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Pneumonia Vaccine market. First, the report provides a basic overview of the Pneumonia Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Pneumonia Vaccine market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Get Discount on This Report: http://www.researchnreports.com/ask_for_discount.php?id=3150 Third, the Pneumonia Vaccine market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What?s more, the Pneumonia Vaccine industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered. In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Complete Report Available at: http://www.researchnreports.com/pharma-healthcare/Global-Pneumonia-Vaccine-Consumption-2016-Market-Research-Report-3150
Просмотров: 1 vil Kudl
Pharmaceutical Supply Chain Integrity and Security: Track & Trace
 
00:59
Pharmaceutical Supply Chain Integrity and Security - Part 1 Regulations in the U.S., Europe and Asia, and international standards Instructor: Arete-Zoe Delivery method: Indirect (Internet) Length: 4 hours of video content CPE credits: n/a The material included in these modules serves many interests by facilitating understanding of construct, dynamics, and influences affecting regulatory policies and corporate decision-making that ultimately determine access, availability, and safety of pharmaceutical products. In the following modules, we will introduce and describe the regulatory environment in the United States, European Union, in major Asian economies such as Japan, India and China, regulatory policies in Russia, and international standards. The video presentations guide students through highly specialized and often disconnected national and supra-nationals regulatory environments that govern pharmaceutical supply chain. Although national variants of Good Distribution Practice guidelines are the key component, they are not the sole focus of this course. Strategic national interests drive national regulatory policies and direct or limit national and international enforcement efforts. Holistic understanding of regulatory environment in global context is essential for understanding of the challenges in pharmaceutical supply chain in the current globalized, inter-connected and inter-dependent economy. Learn more: http://www.aretezoe.com Systems Approach to Training: http://www.aretezoe.com/#!training-/c1hbi
Просмотров: 163 Arete Zoe
Motivational Speaker Sales Conferences, Leadership Sales Convention,  National Sales Events
 
02:07
Have one of the top Motivational Speakers to deliver a powerful keynote at your Sales Conference, Leadership Sales Convention, National Sales Meeting or Regional Sales Event. Limited dates available this year. Make an inquiry for this top sales conference speaker here ► http://goo.gl/qcrOMW Subscribe To the channel of The Man Inspiring Millions Here ► http://goo.gl/xWRDyW ►Imagine if your sales team and senior executives could get charged up like this crowd of 10,000 people? https://www.youtube.com/watch?v=h-ac4fnmztc Do you want your front-line sales team to up their numbers? Is your sales team facing market challenges? Perhaps your Sales Division is doing good. But you want them to do better? Are your sales people having to deal with unfamiliar trends and terrains? Would you like to see your sales exec skill up and sell more? What if we could increase your companies’ bottom line beyond your expectations? Would you be interested? ► Are you ready to have a record breaking sales year? Let The Man Inspiring Millions speak in front of your Sales Executives to light a fire in their heart, expand their minds and give them a kick in the butt to make this year their best year yet. Kevin Abdulrahman is an experienced Sales Motivational Speaker who delivers powerful and easy to execute thoughts and strategies helping executives and groups raise their sales results. The Man Inspiring Millions works with leading companies through delivering his high-energy sales keynotes and training workshops across five continents. So if you want a memorable sales keynote motivational speaker at your Sales Conference, Leadership Sales Convention, National Sales Meeting or Regional Sales Event, then call for Kevin Abdulrahman. More videos from our sales motivational speaker ►Motivational Speaker for ICT Events (Information & Communication Technology) Conferences & Technology Services Conventions https://www.youtube.com/watch?v=Stq1ThgDisI ►Motivational speaker for Annual Automotive global sales and Dealerships marketing conference & Expo https://www.youtube.com/watch?v=4QeuCDKpxZU ►Motivational Speaker for Airlines Annual conferences. Global Meetings, Trainings & Aviation Conventions & Exhibitions https://www.youtube.com/watch?v=PVJOMBzs7p8 ►Motivational Speaker for Annual Investment Meetings. Financial services Expo. Investment Banking. Retail and Commercial Banking. Regional banking. International banking. Investment managers. Enterprise development investment platform. https://www.youtube.com/watch?v=p-8b1hVNsbQ Motivational Speaker to Fortune 500, Global 500, Fortune 1000 and Fast Growth Companies. https://www.youtube.com/watch?v=ycbF2i5Z18A ►Motivational Speaker on Creativity & Innovation https://www.youtube.com/watch?v=nG7eookYrlk ►Visit http://goo.gl/qcrOMW to book Kevin Abdulrahman as your Experienced Motivational Sales Keynote Speaker for your next Sales Conference, Leadership Sales Convention, National Sales Meeting or Regional Sales Event. ►Like us on Facebook: https://www.facebook.com/BestLeadershipSpeakerAsia ►Follow us on Twitter: https://twitter.com/BestSpeakerAsia ►Instagram: https://www.instagram.com/kevin_abdulrahman ► Sales Conference, Leadership Sales Convention, National Sales Meeting and Regional Sales Event Keynote Speaker Profile http://goo.gl/ICXTNu ► Sales Executives Training on Public Speaking, Media, Negotiations & Presentation Skills Training http://goo.gl/GltOFu
Просмотров: 1478 Kevin Abdulrahman
MarketResearchFuture.Com analysts predict aerospace fasteners market to reach $9 billion in 2021
 
17:47
Marketresearchfuture.com predicts the global aerospace fasteners market to reach around $9 billion in 2021 from $6 billion in 2015, to grow at a CAGR of 7.5%. The major factors driving the growth are the growing usage of titanium fasteners, demand for next generation aircraft, growing fleet size and orders, fuel efficient and light weight aircraft. Global and country level analysis is covered to determine the demand and sales forecast for aerospace fasteners and accordingly regional and global companies were covered to understand the current market share, revenue breakup, and forecast production of aerospace fasteners to meet the growing aircraft demand with different specification. The market is further segmented into aircraft class and regions. Under aircraft class, commercial and military aircraft is covered with further deep dive on different aircraft models in both the market. For e.g, A380, B777X, B787, A320 family, B737, B737 MAX and other variants are covered to understand the current and forecast demand for commercial aerospace fasteners. This practice is done for military aircraft models as well. Regional and country level aerospace fasteners demand and key companies’ production were studied to derive at a market number. With historical data, secondary & primary research, insights from key industry experts and data from company website and other association, the facts were verified and triangulated to arrive at a market size. With few assumption, limitation, micro and macro indicators the forecast has been done with the help of in-house data modeling. Market dynamics were covered in detail, to support our insights and numbers. Key drivers, trends, opportunities, and challenges were studied and analyzed. As per MRFR analysis, Commercial Aircraft account 60% of the market in 2016, which is expected to have 62% market share during forecast period. Whereas, geographically Americas will continue its dominance in the forecast period, followed by APAC and EMEA region. Objective 1. Five (5) years market forecast for aerospace fasteners 2. Regional and country specific demand and forecast for aerospace fasteners 3. Key segments covered in the report are: aircraft types and regions 4. Under aircraft type both commercial and military aircraft is taken into consideration 5. In service fleets, current aircraft orders and future deliveries were taken into consideration while forecasting the market for commercial and military fasteners 6. Major aircraft models (for e.g., for commercial aircraft A380, 787, 767, A320 family, B737, B737Max) (for military: transport, combat, and rotorcraft), production and there forecast production capacity and usage of fasteners were kept in consideration in the report scope and same study is done for regional and country level 7. Average selling price for all different aircraft models and fasteners was finalized; same was referred for forecasting, keeping few assumptions into factor 8. Regions covered are: Americas, EMEA, and APAC 9. For all the regions: top companies, forecast demand for aircraft, passenger traffic and fasteners demand were identified and then with historical figure, data collected through primary and annual reports were triangulated to derive the regional market size 10. Under each region, key countries were studied and analyzed Competitive landscape: top OEMs, there production, current sales, future strategies, new programs, and market share were studied derive at market sizing ($XX billion) Key reports to refer: 1. Global Aerospace Composites Market 2016-2021 2. Global Commercial Aircraft Avionics Systems Market 2016-2021 3. Global Aircraft Health Monitoring System Market 2016-2021 4. Global Commercial Aircraft Seat Actuation Market 2016-2021 5. Global Military Aircraft Actuation System Market 2016-2021 6. Global In-flight Entertainment (IFE) Systems Market 2016-2021 7. Global Aircraft Component MRO Market 2016-2021 8. Global Commercial Aircraft Windows and Windshields Market 2016-2021 9. Global Aircraft Seating Market 2016-2021 About Market research Future Market Research Future, a part of WiseGuy Research Consultant Pvt. Ltd., an India based market intelligence and consulting firm offers key insights on niece market to serve the unmet needs of its end customer. With strong market expertise and team of industry analysts, the organization aims at delivering value added service to assist industry leaders in making informed decision and building strategies. At MRFR, research best practices are combined to offer best solution for complex business requirement to facilitate growth (organic and inorganic), business diversification, product and business expansion, and formulate strategies to remain competitive in dynamic business environment.
Просмотров: 838 Wise Guy Research Consultants Pvt Ltd
#EarningsMinute Sun Pharma Registers Steady Q1
 
01:47
Sun Pharma is out with its Q1 numbers. Ekta Batra gives us a lowdown of the company’s Q1 earnings here.
Просмотров: 112 CNBC-TV18
Anonymous - #Op_Pharma
 
03:48
#Op_Pharma is focused on exposing and spreading awareness on the lies and corruption of the Medical system, Pharma Corporations and their whores. The numbers of deaths due to medical negligence and greed, are too high to ignore. Many are waking up to the Pharma lies, it is time to take back the control of our own health, to demand justice for the victims of their greed. Our health is more important than their profit! Join us on exposing what many try to ignore. MISSION: Our aim is to spread health awareness and shine a light on the corruption and crimes of the Medical System and Pharma Industry. OBJECTIVES: - Identify the pigs and revolving door between Government and Corporations (CDC, FDA, Cancer Research, Monstanto...) - Search for whistleblowers and collect Incriminating Data - Research and gather info on related topics - Spread information (The Truth About Cancer, Epigenetics, Nutrition, Prescription Drugs...) http://pastebin.com/zBYhUiCH How to join IRC: anonops.com This operation will be conducted by a branch of Anonymous. Anonymous Loyalist and his team will be focused on #OpTrump2016. - Watch some of our other videos - Anonymous - Panama Papers Leak #OpEvilCorp https://www.youtube.com/watch?v=ULi41RQEMLw Anonymous - Putting on the Digital Mask https://www.youtube.com/watch?v=JeLmLNuTqww Anonymous - Message to Hillary Clinton https://www.youtube.com/watch?v=lLyh-pbmJ4g Anonymous - Message to Sacramento Police https://www.youtube.com/watch?v=GBT7PueAMmw Anonymous Documentary - The Story of the Anonymous Hacktivists Full Documentary https://www.youtube.com/watch?v=POLIYRMB0J8
Просмотров: 456 Guy Fawkes
In the land of pharma, Belgium is King
 
05:25
Просмотров: 3216 pharma.be
Become a Automotive Recruiter
 
02:40
Sales recruiting, automotive sales, motivational speaking
Просмотров: 64 Auto Sales Institute, Inc.
Christi Shaw: Experiencing cancer side by side
 
01:30
Christi Shaw, former President, US Novartis speaking to Paul Simms, eyeforpharma at eyeforpharma Philadelphia on what she sees the impact will be of her taking time out of her career to care for her sister. eyeforpharma’s youtube channel now broadcasts the best presentations, chats and interviews from our conferences. eyeforpharma’s mission is to make the pharmaceutical industry more open and valued. Our conferences are where leading minds gather to discuss and share strategies that drive value for patients and shine a light on pharma excellence. Look for talks on patient-centricity, multi-channel marketing, value-added services, real-world data and sales force effectiveness. Get the latest industry insights in your inbox: http://social.eyeforpharma.com/ Follow eyeforpharma on Twitter: http://www.twitter.com/eyeforpharma Like eyeforpharma on Facebook: http://www.facebook.com/eyeforpharma Subscribe to our channel: http://www.youtube.com/user/eyeforpharma
Просмотров: 143 eyeforpharma
Global Oncology Drug Delivery Consumption Market Drivers and Challenges Report 2021
 
00:41
“Global Oncology Drug Delivery Consumption Industry 2016 Market Research Report” Order This Report by calling ResearchnReports.com at +1-888-631-6977. Get Sample Copy of This Report: http://www.researchnreports.com/request_sample.php?id=1897 The Global Oncology Drug Delivery Consumption 2016-2021 Market Research Report is a professional and in-depth study on the current state of the Oncology Drug Delivery market. First, the report provides a basic overview of the Oncology Drug Delivery industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Oncology Drug Delivery market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Oncology Drug Delivery market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Oncology Drug Delivery industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered. In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Просмотров: 1 Ruth Martin
Abdelazim Zaghloul  | Kuwait  | Pharmaceutics & Novel   2016 | Conferenceseries LLC
 
26:36
8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain Preparation and in-vitro/in-vivo evaluation of metformin hydrochloride rectal dosage form Click here for Abstract and Biography: http://novel-drugdelivery-systems.pharmaceuticalconferences.com/speaker/2016/abdelazim-zaghloul-kuwait-university-kuwait
Просмотров: 42 Pharmaceutical Conferences
How to Compensate a Salesperson for your Property Management Company | The Property Management Show
 
31:15
How long did it take you to get to 300 doors? - It took about three years. I decided to hire someone because I was a good salesperson but not a great one, and I was doing business development and sales 10 to 20 percent of the time during the day. I knew if I could find someone to do it better than me full-time, I would grow. I was averaging 100 units a year when it was just me, and then when I brought in a salesperson, that growth went to 300-plus units a year.. WEBSITE: http://everythingpropertymanagement.com/ Property Management Marketing: http://fourandhalf.com How to Compensate a Property Management Salesperson The topic today is how to compensate a salesperson for your property management company. If we have a chance, we’ll talk about when you should hire that salesperson and shed some light on how to find and interview and retain the best salespeople for your property management shop. Our guest is Duke Dodson who runs Dodson Property Management. He has one of the fastest growing property management companies in the U.S., and he’s uniquely positioned to talk about this. Q: Thanks for joining us, Duke. Tell us a little about your company and your story. When did you first decide to hire a salesperson? How far along were you in your growth trajectory? A: I started my company in 2007. It was just me, so I was the business development person and the salesperson. When I got to the point that we had 300 units under management, I hired the first salesperson. Q: There is something to be said about setting up systems to be able to accept this kind of growth. For most property managers, growing by 10 properties a month is a good goal. So 300 a year is a great launching pad. I don’t know of any information in NARPM or the general property management industry that talks about sales compensation. So how did you come up with a strategy? A: There was no roadmap early on, so I had to make it up. I looked at the type of person I wanted in the role and then I had to figure out the compensation model that person would be comfortable with. It’s rare to find someone with property management experience and sales experience. So unless you’re going to poach this person from another company, it’s going to be difficult for a property manager to find a salesperson with experience in single family management. I looked at other salespeople I might want to attract. Pharmaceutical and medical sales seemed the way to go because these are high energy, results-driven professionals. So I looked at those models. Some had a small salary plus commission and others worked solely on commission. I liked those models. So with our first salesperson, I provided a straight commission and no salary. I built it so that if he did well in the first year, then his compensation would increase in the second, third and fourth years, so it would be hard to walk away. He could earn a great income if he performed. Q: So you used a recurring compensation plan. He got to eat a bit of what he killed over time and each account brought him a percentage. A: Right, if he brought in a single family home for us to manage, he earned 25 percent of all the revenue associated with that property for one year. Then if he retained the property under our management in year 2 and 3, he’d continue to earn 15 percent. In year four, the commission would drop off. Q: That’s a lot of money. A: I learned that the industry standard was similar to that, and I also learned that you get what you pay for. If you want that top notch rainmaker, they will need to make a good living and you’ll have to compensate appropriately. But you may not need a rainmaker. If you’re getting a lot of warm leads from SEO and content, you don’t necessarily need a rainmaker, you need someone with good sales structure and organizational skills who can do presentations. That person doesn’t need to make $150,000 a year. You’ll find a good salesperson who can earn $60,000 or $80,000 a year. If you’re paying high rainmaker numbers, make sure they are bringing in a lot of business. Q: So for a younger company, it made sense to pay your salesperson a full commission of 25 percent
Просмотров: 817 The Property Management Show
PCD Pharma Franchise
 
01:21
Apikos Pharma is a rapidly growing PCD and pharma franchise company in India. Being an ISO 9001:2008 global pharmaceutical company, we offer a vast product range consisting of tablets, capsules, syrups, injections, protein supplements and Ayurvedic products, all approved by Drug Controller General of India (DCGI). From raw materials to processed drugs, we always comply with the industry standards to deliver high quality, pure and effective products to the society. Our Products offer not only higher margins but also ensures quality with timely deliveries. We are interested in direct supplies to whole sale chemists, pharma distributors/ stockist, Medical Representatives/ Area Sales Manager/ Regional Sales Manager for ethical promotion of our quality product range. We have in our portfolio, a wide range of products, either different in formulations or having advance technology & having certain U.S.Ps. (Unique selling propositions) which keeps our brand above the mushrooms of many "ME Too's" in the market. To become a reputed Pharmaceutical Company in India in sphere of excellence and quality products and be the first choice of every customer by providing them value for money. If you are interested in operating as a franchise anywhere or in unrepresented India, then get in touch at the below mentioned contact numbers - +91-9855087879 for: Franchise Opportunity/Pharma PCD/ Pharma Franchise/ Pharma PCD Franchise pikos Pharma is headed by Mr. Harish Sharma and Mr. Anil kapoor who had rich experience of pharmaceutical industry at different level in management category in various reputed companies. There able guidance has propelled us to a prominent position in this highly competitive industry and their quality driven approach inspires us to provide our partner the best products in the market. Apikos Pharma is a ISO 9001-2008 Certified Chandigarh based pharmaceutical company having operation in all over India. Apikos Pharma is with a powerful combination of skills, resources and our support system that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
Просмотров: 4603 apikos pharma
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Oral Argument - October 15, 2014
 
59:22
Facts: Sandoz, Inc., (Sandoz) and Mylan Pharmaceuticals, Inc. (Mylan) submitted Abbreviated New Drug Applications (ANDAs) to the Food and Drug Administration (FDA) to produce and market generic versions of Copaxone, a drug used to treat Multiple Sclerosis. Teva Pharmaceuticals USA, Inc., the manufacturer of the original drug, sued Sandoz and Mylan and used two different types of claims that are based on different ways to use molecular weight to distinguish between polymer samples. The district court did not distinguish between the different methods of using molecular weight and held that the claims were not indefinite as Sandoz and Mylan argued. After a bench trial, the district court held that the Sandoz and Mylan products infringed on Teva's patent. The U.S. Court of Appeals for the Federal Circuit held that the district court did not error in holding that the patents were infringed, but that some of the claims had not been effectively shown to be definite. Question: Can a district court's finding of fact in the construction of a patent claim be reviewed de novo , as though for the first time, which the U.S. Court of Appeals for the Federal Circuit requires and did in this case? Conclusion: No. Justice Stephen G. Breyer delivered the opinion for the 7-2 majority. The Court held that a federal appellate court could only overturn a district court's finding of fact if those findings were determined to be "clearly erroneous." Federal Rule of Civil Procedure 52(a)(6) established this standard without any exceptions, and there was no reason to create one in this case. Because the construction of a patent claim is essentially a factual determination, it should be governed by this well-established standard. Therefore, while an appellate court may still review a lower court's construction of a claim de novo , to overturn the lower court's ruling, the appellate court must find that the lower court has made a clear error with respect to the findings of fact. Justice Clarence Thomas wrote a dissent in which he argued that the construction of patent claims deals with questions of law, so Federal Rule of Procedure 52(a)(6), which only applies to questions of fact, is not the controlling standard. Instead, the appellate court was correct to apply a de novo standard of review, which increases uniformity. Justice Thomas wrote that a district court's determination is factual in nature when it deals with the historical fact of the case, as in the case of contracts and deeds, while it is a legal conclusion when it defines rules applicable beyond the specifics of the case at hand, as in the case of statutes. Based on this definition, the construction of patent claims should be considered a question of law. Justice Samuel A. Alito, Jr. joined in the dissent. For more information about this case see: https://www.oyez.org/cases/2014/13-854 Section 1: 00:00:05 Section 2: 00:22:52 Section 3: 00:33:10 Section 4: 00:56:14 PuppyJusticeAutomated videos are created by a program written by Adam Schwalm. This program is available on github here: https://github.com/ALSchwalm/PuppyJusticeAutomated The audio and transcript used in this video is provided by the Chicago-Kent College of Law under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License. See this link for details: https://creativecommons.org/licenses/by-nc/4.0/
Просмотров: 221 PuppyJusticeAutomated
Healthcare: How To Evaluate Healthcare M&A Deals *** INDUSTRY FOCUS ***
 
19:30
On this episode, Motley Fool analysts explain how to break down biotech mergers and acquisitions. This podcast was recorded on Jan 6, 2016. Imagine owning Amazon.com (up over an insane 4,000% since 2001) when Internet sales rendered big-box retailers obsolete... Now an industry 99% of us use daily is set to implode... And 3 established companies are positioned to take advantage. Click http://bit.ly/1zQXjzy for a stunning presentation. ------------------------------------------------------------------------ Subscribe to The Motley Fool's YouTube Channel: http://www.youtube.com/TheMotleyFool Or, follow our Google+ page: https://plus.google.com/+MotleyFool/posts Inside The Motley Fool: Check out our Culture Blog! http://culture.fool.com Join our Facebook community: https://www.facebook.com/themotleyfool Follow The Motley Fool on Twitter: https://twitter.com/themotleyfool
Просмотров: 759 The Motley Fool
Redx Pharma CEO on resistant superbugs and pipeline deals
 
08:45
Neil Murray, chief executive of Redx Pharma Plc (LON:REDX), welcomes this week’s UK government report on how to tackle the growing resistance to antibiotics. Statistics reveal that without action there will be 10mln extra deaths at a cost of US$100trn by 2050. Murray says this equates to one person dying every three seconds from resistant infection which is a higher cause of death than cancer is today. Redx is working on multiple treatments to tackle all superbugs. Due to the nature and the severity of the problem Murray and his team anticipated more and large companies returning to the space and “we wanted to be in a position where we had those pipeline assets.” The biotech company is having negotiations about its pipeline and Murray is confident further deals will be secured “in due course.” Murray explains there hasn’t been a new class of antibiotics in a generation, and Redx’s antibacterial compounds represent “potentially that first new class and that’s very exciting.”
Просмотров: 184 Proactive Investors Stocktube
How To Write a Business Plan To Start Your Own Business
 
08:50
Start Your Own Business by Writing Business Plan. How to write a successful business plan for successful startups. Step By Step - How to write a business plan an effectively for starting your own business. Watch 11 Elements of Sample Business Plan - https://www.youtube.com/watch?v=i1b0_UdeOTI TOP 10 TIPS Before Starting Your OWN BUSINESS : https://youtu.be/wxyGeUkPYFM Join our Young Entrepreneurs Forum - http://www.youngentrepreneursforum.com/ #youngentrepreneursforum Do you need a business plan for successful startups in India, USA, UK & Canada. Starting an own business needs working plan which compiles some important details about product & company. Problem Solving Skills To Start a Small Business - https://www.youtube.com/watch?v=I9Ho3jFvq6I #startsmallbusiness 9 Steps For Writing a Business Plan - Required Steps to Write a Business Plan for your company or service. Step 1 - Define your vision 1:16 Step 2 - Set your goals and objectives for the business 1:50 Step 3 - Define your Unique Selling Proposition 2:29 Step 4 - Know your market 3:02 Step 5 - Know your customer 3:57 Step 6 - Research the demand for your business 4:47 Step 7 - Set your marketing goals 5:52 Step 8 - Define your marketing strategy 6:38 Step 9 - Take Action! 7:20 These all Steps are very important while you are writing a business plan for starting your own business. Life of Riley by Kevin MacLeod is licensed under a Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1400054 Artist: http://incompetech.com/ You must have to focus on Idea, Product,Strategy,Team, Marketing and Profit while you are writing business plan for your successful stratups.
Просмотров: 789057 Young Entrepreneurs Forum
American Medical Association Complicity with Big Tobacco
 
04:43
Mainstream medicine’s permissive attitude towards smoking in the face of overwhelming evidence can be an object lesson for contemporary medical collusion with the food industry. Subscribe to Dr. Greger’s free nutrition newsletter at https://www.nutritionfacts.org/subscribe and get a free recipe from his new HOW NOT TO DIE COOKBOOK. (All proceeds Dr. Greger receives from the sales of his books, DVDs, and speaking engagements go to support the 501c3 nonprofit that runs NutritionFacts.org.) If the balance of scientific evidence favors plant-based eating, why isn’t the medical profession at the forefront of encouraging people to eat healthier? That’s the question this video tries to answer. Looking back to smoking in the 1950’s, you can see how all of society, the government, and the medical profession itself could be in favor of habits that decades of science had already overwhelmingly condemned as harmful. More on the influence industry can have on food policy: • The McGovern Report (http://nutritionfacts.org/video/the-mcgovern-report/) • Seeing Red No. 3: Coloring to Dye For (http://nutritionfacts.org/video/seeing-red-no-3-coloring-to-dye-for/) • Who Determines if Food Additives are Safe? (http://nutritionfacts.org/video/who-determines-if-food-additives-are-safe/) • Salmonella in Chicken & Turkey: Deadly But Not Illegal (http://nutritionfacts.org/video/salmonella-in-chicken-turkey-deadly-but-not-illegal/) • Collaboration with the New Vectors of Disease (http://nutritionfacts.org/video/collaboration-with-the-new-vectors-of-disease/) • Taxpayer Subsidies for Unhealthy Foods (http://nutritionfacts.org/video/taxpayer-subsidies-for-unhealthy-foods/) • Big Sugar Takes on the World Health Organization (http://nutritionfacts.org/video/big-sugar-takes-on-the-world-health-organization) • Food Industry Funded Research Bias (http://nutritionfacts.org/video/food-industry-funded-research-bias/) • Big Food Using the Tobacco Industry Playbook (http://nutritionfacts.org/video/big-food-using-the-tobacco-industry-playbook) • The Healthy Food Movement: Strength in Unity (http://nutritionfacts.org/video/the-healthy-food-movement-strength-in-unity/) Have a question for Dr. Greger about this video? Leave it in the comment section at http://nutritionfacts.org/video/american-medical-association-complicity-big-tobacco and he'll try to answer it! http://www.NutritionFacts.org • Facebook: http://www.facebook.com/NutritionFacts.org • Twitter: http://www.twitter.com/nutrition_facts • Podcast: http://nutritionfacts.org/audio/ • Subscribe: http://http://nutritionfacts.org/subscribe/ • Donate: http://www.NutritionFacts.org/donate
Просмотров: 25486 NutritionFacts.org
British pound holds firm against USD
 
03:09
While the future of the United Kingdom in the event of a Brexit is being debated by media outlets, pundits and financial market participants, the Office for National Statistics has revealed some encouraging news. Official data released earlier in the day showed that the UK’s manufacturing production posted a stronger-than-expected advance, boosting optimism about the country’s economic outlook. The report indicated that manufacturing production in the UK surged by a seasonally adjusted 2.3 percent in April, beating the forecast for a marginal gain of 0.1 percent. In the previous month, the country’s manufacturing output grew by a mere 0.1 percent. On a year-on-year basis, manufacturing production printed a rise of 0.8 percent following the March decline of 1.9 percent. Analysts had anticipated yet another drop of 1.5 percent in April. Today’s figures also suggest that UK industrial production jumped by 2 percent in April, easily exceeding expectations for a zero gain. In annual terms, the indicator climbed by 1.6 percent after shedding 0.2 percent in March. Such an impressive advance was driven by an increase in the pharmaceutical industry as well as improving car production, aided by stronger domestic demand and robust sales outside the UK. The market absorbed the latest slew of statistics instantly. However, the British pound was rather slow to react to the upbeat data. Bouncing off its daily lows, the cable extended gains, currently trading around 1.4547 levels. Currency strategists point out that the situation is unclear for dollar bulls, who are unsure whether it would be a good idea to purchase the greenback amid the current economic turmoil. As for the pound, with Brexit risks looming in Europe, many traders are hesitant to buy the British pound ahead of the upcoming referendum this month. At present, the most recent Brexit polls suggest that most Britons are ready to vote to leave the European Union, which raises a lot of doubts among investors. At the same time, economists warn market players about the gloomy economic consequences the UK will have to face if it decides to remove itself as a member of the bloc. Therefore, as cautious trading persists, the foreign exchange market is putting in a relatively steady performance without much volatility. https://www.instaforex.com/ru/
Просмотров: 206 instaforex
Hyperinflation 2016 - John Williams Feb 2016 Interview
 
40:49
Gold Could go Vertical Soon, How to Profit Like an Insider: http://CrushTheStreet.com/Insider Subscribe to our Free Financial Newsletter: http://crushthestreet.com VISIT GUEST: http://shadowstats.com TOPICS 1:40 Unemployment Rate Lies, Manufacturing Jobs Number Misleading 6:05 Free Trade Effects on Economies 9:30 How US Unemployment & Labor Force Numbers Are Rigged 14:40 Retail Sales Figures & Inflation 24:00 We're In a Recession, Economy Never Recovered, Political Turmoil Approaching 29:00 The Central Banks are Out of Options 34:40 Inflation vs Deflation, Potential Return to Gold Standard Mr. Williams was born in 1949. He received an A.B. in Economics, cum laude, from Dartmouth College in 1971, and was awarded a M.B.A. from Dartmouth's Amos Tuck School of Business Administration in 1972, where he was named an Edward Tuck Scholar. During his career as a consulting economist, John has worked with individuals as well as Fortune 500 companies. Although I am known formally as Walter J. Williams, my friends call me “John.” For 30 years, I have been a private consulting economist and, out of necessity, had to become a specialist in government economic reporting. One of my early clients was a large manufacturer of commercial airplanes, who had developed an econometric model for predicting revenue passenger miles. The level of revenue passenger miles was their primary sales forecasting tool, and the model was heavily dependent on the GNP (now GDP) as reported by the Department of Commerce. Suddenly, their model stopped working, and they asked me if I could fix it. I realized the GNP numbers were faulty, corrected them for my client (official reporting was similarly revised a couple of years later) and the model worked again, at least for a while, until GNP methodological changes eventually made the underlying data worthless. That began a lengthy process of exploring the history and nature of economic reporting and in interviewing key people involved in the process from the early days of government reporting through the present. For a number of years I conducted surveys among business economists as to the quality of government statistics (the vast majority thought it was pretty bad), and my results led to front page stories in 1989 in the New York Times and Investors Daily (now Investors Business Daily), considerable coverage in the broadcast media and a joint meeting with representatives of all the government's statistical agencies. Nonetheless, the quality of government reporting has deteriorated sharply in the last couple of decades. Reporting problems have included methodological changes to economic reporting that have pushed headline economic and inflation results out of the realm of real-world or common experience. Over the decades, well in excess of 1,000 presentations have been given on the economic outlook, or on approaches to analyzing economic data, to clients—large and small—including talks with members of the business, banking, government, press, academic, brokerage and investment communities. I also have provided testimony before Congress (details here). An old friend—the late-Doug Gillespie—asked me some years back to write a series of articles on the quality of government statistics. The response to those writings (the Primer Series available at the top-center of this page) was so strong that we started ShadowStats.com (Shadow Government Statistics) in 2004. The newsletter is published as part of my economic consulting services. — John Williams
Просмотров: 15234 FutureMoneyTrends.com
Former FDA Head Breaks Silence on America’s Opioid Epidemic
 
05:27
The opioid epidemic in the US has been deemed as one of the “great mistakes of modern medicine”, according to the former head of the Food and Drug Administration, Dr. David Kessler. Dr. Kessler acknowledges the responsibility of pharmaceutical companies as well as physicians in the overdosing of America and notes that opioid addiction is in fact, an American disease. From 1994-2014 opioid sales quadrupled, with roughly 78 people dying each day from opioid abuse. “The inappropriate promotion of drugs contributed significantly to this epidemic. Because drug companies took a small piece, a sliver of science and widely promoted it as not being addictive. That was false.” according to Dr. Kessler, who also admitted that he should have pushed for stricter prescription practices when he was still in charge. The Obama administration is distributing $11 million to states for the overdose reversal drug called Narcan to try and combat the ongoing epidemic. Joya Mia Italiano and Elliot Hill take a closer look on the Lip News. http://www.cbsnews.com/news/former-fda-head-doctor-david-kessler-opioid-epidemic-one-of-great-mistakes-of-modern-medicine/ Newest Lip News playlist: https://www.youtube.com/watch?v=5ST_JB9XIhw&index=1&list=PLPnLjoW07bV2hUGhMAd26ExGg93FzJAzQ&nohtml5=False The Journalists: https://www.youtube.com/watch?v=BWnCGALkFf0&index=1&list=PLjk3H0GXhhGfqe9hDJc8fi5qy-kDXW3r0&nohtml5=False CRIME TIME clips playlist – https://www.youtube.com/watch?v=Kr143vXWrpw&list=PLjk3H0GXhhGeC9DbpSnIvd2i9BHh2dBvv&index=1&nohtml5=False BYOD (Bring Your Own Doc) Highlight Videos- https://www.youtube.com/watch?v=sAtgk6rZGmw&list=PLjk3H0GXhhGeu2DCf6Ouo7hTsA5QB2MAL&index=1&nohtml5=False MEDIA MAYHEM short videos playlist - https://www.youtube.com/watch?v=q8QiHbI-YYY&index=1&list=PLjk3H0GXhhGcz4un-zws5sMlCLk3NNjDP&nohtml5=False http://www.thelip.tv https://www.facebook.com/thelip.tv
Просмотров: 972 TheLipTV2
ASTELLAS CORPORATE FILM
 
02:00
Просмотров: 298 Human Resources
Healthcare: Breaking Down Pfizer's Break-Up With Allergan *** INDUSTRY FOCUS ***
 
20:15
The ins-and-outs of Pfizer and Allergan's failed $160 billion merger. This podcast was recorded on Apr. 6, 2016. Imagine owning Amazon.com (up over an insane 4,000% since 2001) when Internet sales rendered big-box retailers obsolete... Now an industry 99% of us use daily is set to implode... And 3 established companies are positioned to take advantage. Click http://bit.ly/1zQXjzy for a stunning presentation. ------------------------------------------------------------------------ Subscribe to The Motley Fool's YouTube Channel: http://www.youtube.com/TheMotleyFool Or, follow our Google+ page: https://plus.google.com/+MotleyFool/posts Inside The Motley Fool: Check out our Culture Blog! http://culture.fool.com Join our Facebook community: https://www.facebook.com/themotleyfool Follow The Motley Fool on Twitter: https://twitter.com/themotleyfool
Просмотров: 200 The Motley Fool